CA2421620A1 - Promoter sequences - Google Patents

Promoter sequences Download PDF

Info

Publication number
CA2421620A1
CA2421620A1 CA002421620A CA2421620A CA2421620A1 CA 2421620 A1 CA2421620 A1 CA 2421620A1 CA 002421620 A CA002421620 A CA 002421620A CA 2421620 A CA2421620 A CA 2421620A CA 2421620 A1 CA2421620 A1 CA 2421620A1
Authority
CA
Canada
Prior art keywords
foxc2
pro
ala
gly
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002421620A
Other languages
English (en)
French (fr)
Inventor
Sven Enerback
Katarina Krook
Lena Rondahl
Wyeth W. Wasserman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LeanGene AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003435A external-priority patent/SE0003435D0/xx
Priority claimed from SE0004102A external-priority patent/SE0004102D0/xx
Application filed by Individual filed Critical Individual
Publication of CA2421620A1 publication Critical patent/CA2421620A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Seasonings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA002421620A 2000-09-26 2001-09-26 Promoter sequences Abandoned CA2421620A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SE0003435A SE0003435D0 (sv) 2000-09-26 2000-09-26 Promoter sequences
SE0003435-5 2000-09-26
US23889700P 2000-10-10 2000-10-10
US60/238,897 2000-10-10
SE0004102-0 2000-11-09
SE0004102A SE0004102D0 (sv) 2000-11-09 2000-11-09 Promoter sequences II
PCT/SE2001/002098 WO2002027008A1 (en) 2000-09-26 2001-09-26 Promoter sequences

Publications (1)

Publication Number Publication Date
CA2421620A1 true CA2421620A1 (en) 2002-04-04

Family

ID=27354602

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002421620A Abandoned CA2421620A1 (en) 2000-09-26 2001-09-26 Promoter sequences

Country Status (5)

Country Link
EP (1) EP1320623A1 (de)
JP (1) JP2004510417A (de)
AU (1) AU2001292481A1 (de)
CA (1) CA2421620A1 (de)
WO (1) WO2002027008A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003064467A1 (en) * 2002-01-29 2003-08-07 Biovitrum Ab A complex of a human foxc2 protein and a foxc2-interacting protein
WO2005035793A2 (en) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Cckar markers and haplotypes associated with extreme weight conditions
SE0400489D0 (sv) * 2004-02-27 2004-02-27 Biovitrum Ab Therapeutic proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701963D0 (sv) * 1997-05-26 1997-05-26 Pharmacia & Upjohn Ab Novel transcription factor
ATE304552T1 (de) * 2000-02-18 2005-09-15 Leangene Ab Methoden zur identifizierung von zusammensetzungen, die für die behandlung von fettleibigkeit nützlich sind, unter verwendung von foxc2

Also Published As

Publication number Publication date
WO2002027008A1 (en) 2002-04-04
JP2004510417A (ja) 2004-04-08
AU2001292481A1 (en) 2002-04-08
EP1320623A1 (de) 2003-06-25

Similar Documents

Publication Publication Date Title
KR100942116B1 (ko) 유전자 전사 조절 성질을 포함하는 디엔에이 서열 및 이러한 디엔에이 서열을 탐지하고 이용하는 방법
KR102287184B1 (ko) 개선된 단백질 또는 펩타이드 발현을 위한 인공 핵산 분자
AU2021290257A1 (en) Globin gene therapy for treating hemoglobinopathies
Xiao et al. Characterization of large yellow croaker (Pseudosciaena crocea) β-actin promoter supports β-actin gene as an internal control for gene expression modulation and its potential application in transgenic studies in fish
Fu et al. Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the β-globin gene
Robinson et al. c-jun inhibits insulin control element-mediated transcription by affecting the transactivation potential of the E2A gene products
Pan et al. An intronic polyadenylation site in human and mouse CstF-77 genes suggests an evolutionarily conserved regulatory mechanism
Kim et al. The skeletal muscle α-actin gene of channel catfish (Ictalurus punctatus) and its association with piscine specific SINE elements
Takei et al. Gm7325 is MyoD-dependently expressed in activated muscle satellite cells
KR100951759B1 (ko) 유전자 전사 조절 성질을 포함하는 디엔에이 서열 및이러한 디엔에이 서열을 탐지하고 이용하는 방법
Krstic et al. Regulation of SOX3 gene expression is driven by multiple NF-Y binding elements
CA2421620A1 (en) Promoter sequences
Cai et al. hnulp1, a basic helix-loop-helix protein with a novel transcriptional repressive domain, inhibits transcriptional activity of serum response factor
CN113874512A (zh) 诱导毛细胞分化的组合物和方法
KR100454621B1 (ko) 췌장도 세포에서 stf-1의 발현을 자극하는 화합물의 특성확인을 위한 신규한 방법
AU760608B2 (en) Novel promoter sequences of myostatin gene
US20020090707A1 (en) Promoter sequences
Smits et al. Molecular cloning and characterization of the mouse Ecm1 gene and its 5′ regulatory sequences
Pi et al. A novel human SCAN/(Cys) 2 (His) 2 zinc-finger transcription factor ZNF323 in early human embryonic development
Yu et al. Comparative analysis of the pig BAC sequence involved in the regulation of myostatin gene
Uwanogho et al. The intergenic region between the Mouse Recql4 and Lrrc14 genes functions as an evolutionary conserved bidirectional promoter
KR20000057698A (ko) 기본-나선-루프-나선 비에이치엘에이치 패밀리의 폴리펩티드 및상응하는 핵산서열
Deng et al. ZNF552, a novel human KRAB/C2H2 zinc finger protein, inhibits AP-1-and SRE-mediated transcriptional activity
Pankratova et al. Alternative Promoters and Tissue-Specific Regulation of Mouse oct-1 Gene Transcription
Karagianni et al. Novel adenomatous polyposis coli gene promoter is located 40 kb upstream of the initiating methionine

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead